Clinical trials recruiting for High Grade Ovarian Serous Adenocarcinoma
Fewer than 3 recruiting trials found.
2
Recruiting trials
2
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Modi-1 Moditope | 1 |
| Pembrolizumab | 1 |
| ZM008 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
- This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Related conditions
Trials recruiting for High Grade Ovarian Serous Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Triple-negative breast cancer 138Breast cancer 2239Urothelial Carcinoma 29Squamous Cell Carcinoma of the Head and Neck 5Renal Cell Cancer 7Prostate cancer 1234Pancreatic cancer 870Pancreas Adenocarcinoma 19Non-small cell lung cancer 507Lung cancer 2180
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for High Grade Ovarian Serous Adenocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.